Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.5900 (4.67%) ($17.8100 - $18.7400) on Thu. Apr. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.99% (three month average) | RSI | 53 | Latest Price | $18.5900(4.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1% a day on average for past five trading days. | Weekly Trend | HALO advances 2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(45%) ARKG(44%) XBI(44%) | Factors Impacting HALO price | HALO will decline at least -1.995% in a week (0% probabilities). VIXM(-31%) VXX(-14%) UUP(-13%) TLT(-3%) IYT(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.995% (StdDev 3.99%) | Hourly BBV | 0 () | Intraday Trend | 3.5% | | | |
|
5 Day Moving Average | $18.17(2.31%) | 10 Day Moving Average | $17.6(5.62%) | 20 Day Moving Average | $17.26(7.71%) | To recent high | -14.8% | To recent low | 33.7% | Market Cap | $2.541b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |